Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1987-11-25
|
| pubmed:abstractText |
A new quinolone antibacterial, ciprofloxacin, was evaluated as oral prophylaxis for transurethral resection of the prostate in a randomised controlled trial. A 3-day course of perioperative ciprofloxacin 250 mg twice daily reduced the post-operative infection rate, the post-operative hospital stay and the frequency of infective complications. Ciprofloxacin was well tolerated and no significant haematological or biochemical side effects were detected.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0007-1331
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
60
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
153-6
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:3311275-Bacteriuria,
pubmed-meshheading:3311275-Ciprofloxacin,
pubmed-meshheading:3311275-Clinical Trials as Topic,
pubmed-meshheading:3311275-Humans,
pubmed-meshheading:3311275-Male,
pubmed-meshheading:3311275-Prostatectomy,
pubmed-meshheading:3311275-Random Allocation,
pubmed-meshheading:3311275-Surgical Wound Infection
|
| pubmed:year |
1987
|
| pubmed:articleTitle |
Oral ciprofloxacin as prophylaxis in transurethral resection of the prostate.
|
| pubmed:affiliation |
Department of Medical Microbiology, London Hospital.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|